Adhesion prevention agents for gynaecological surgery: An overview of Cochrane reviews

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 6, 2015, Pages

  Hindocha, Akshay ^a   Beere, Lawrence ^a   Dias, Sofia ^b   Watson, Andrew ^c   Ahmad, Gaity ^a  

^a PENNINE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c TAMESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; ADJUVANT; CARBOXYMETHYLCELLULOSE; DEXTRAN; FERRIC HYALURONIC ACID; FIBRIN; GONADORELIN AGONIST; HARTMANN SOLUTION; HEPARIN; HYALURONIC ACID; ICODEXTRIN; MACROGOL; N,O CARBOXYMETHYL CHITOSAN; NOXYTIOLIN; OXIDIZED REGENERATED CELLULOSE; POLITEF; PROMETHAZINE; RETEPLASE; SODIUM CHLORIDE; STEROID; UNCLASSIFIED DRUG;

ADHESION; BIRTH RATE; DRUG EFFICACY; DRUG SAFETY; ECTOPIC PREGNANCY; GYNECOLOGIC SURGERY; HUMAN; LIVE BIRTH; PELVIC PAIN; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SECOND LOOK SURGERY; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; ADVERSE EFFECTS; FEMALE; LITERATURE; TISSUE ADHESIONS;

FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; PELVIC PAIN; REVIEW LITERATURE AS TOPIC; TISSUE ADHESIONS;

EID: 85017315328     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011254.pub2     Document Type: Review

References (41)

1. Ahmad G, Duffy JMN, Farquhar C, Watson A. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews 2014, Issue 11.
2. Ahmad G, Mackie FL, Iles DA, O'Flynn H, Dias S, Metwally M, Watson A. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews 2014, Issue 7. [DOI: 10.1002/14651858]
3. Adhesion Study Group (Buttram V, Malinak R, Cleary R, Cohen S, Cowan B, Daniell J, et al). Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility 1983;40:612-9.
4. Bakkum EA, Trimbos-Kemper TC. Natural course of postsurgical adhesions. Microsurgery 1995;16(9):650-4.
5. Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Canadian Medical Association Journal 2004;170:477-80.
6. Bosteels J, Weyers S, Kasius J, Broekmans FJ, Mol BWJ, D'Hooghe TM. Anti-adhesion therapy following operative hysteroscopy for treating female subfertility. Cochrane Database of Systematic Reviews May 2014, Issue 1.
7. Cheong Y, Laird S, Li T, Shelton K, Ledger W, Cooke I. Peritoneal healing and adhesion formation/reformation. Human Reproduction Update 2011;7:556-66.
8. Cheong Y, Reading I, Bailey S, Sadek K, Ledger W, LI T. Should women with chronic pelvic pain have adhesiolysis?. BMC Women's Health 2014;14:36.
9. De Wilde RL. Post market study for an adhesion barrier following laparoscopic myomectomy. http://clinicaltrials.gov/show/NCT00891657.
10. Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertility and Sterility 1996;66(6):904-10.
11. Diamond MP. Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo controlled multicenter study. Fertility and Sterility 1998;69(6):1067-74.
12. Diamond M, Freeman M. Clinical implications of postsurgical adhesions. Human Reproduction Update 2001;7:567-76.
13. Diamond M, Wexner S, diZereg G, Korell M, Zmora O, Van Goor H, Kamar M. Adhesion prevention and reduction: Current status and future recommendations of a Multinational Interdisciplinary Consensus Conference. Surgical Innovation 2010;17(3):183-8.
14. ® adhesion barrier: a review of the clinical literature on intraabdominal use. Gynecological Surgery 2012;9(3):247-57.
15. diZerega G. Contemporary adhesion prevention. Fertility and Sterility 1994;61:219-35.
16. Hammoud A, Gago L, Diamond M. Adhesions in patients with chronic pelvic pain: a role for adhesiolysis?. Fertility and Sterility 2004;82:1483-91.
17. Haney A, Hesla J, Hurst B, Kettel M, Murphy A, Rock J, et al. Prevention of pelvic side wall adhesion reformation using surgical barriers: Expanded polytetrafluororethylene (Gore-Tex surgical membrane) is superior to oxidised regenerated cellulose (Interceed TC7). Fertility and Sterility 1994;210:265.
18. Hindocha A, Beere L, Dias S, Watson A, Ahmad G. Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 05/08/2014, Issue 1.
19. Hosie K, Gilbert JA, Kerr D, Brown CB, Peers EM. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Delivery 2001;8(1):9-12.
20. Johns DB, Keyport GM, Hoehler F, di Zerega GS. Reduction of postsurgical adhesion with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynaecologic surgery. Fertility and Sterility 2001;76(3):595-604.
21. Kumar S, Wong P, Leaper D. Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gyneacological abdominal surgery. Cochrane Database of Systematic Reviews 2009, Issue 1, DOI 10.1002/14651858.CD005080.
22. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
23. Li TC, Cooke ID. The value of an absorbable adhesion barrier, Interceed, in the prevention of adhesion reformation following microsurgical adhesiolysis. British Journal of Obstetrics and Gynaecology 1994;101(4):335-9.
24. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young R. Peritoneal adhesions: Etiology, pathophysiology, and clinical significance. Digestive Surgery 2001;18:260-73.
25. Lower AM, Hawthorn RJS, Emeritus HE, O'Brien F, Buchan S, Crowe AM. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. British Journal of Obstetrics and Gynaecology 2000;107:855-62.
26. Lower AM, Hawthorn RJ, Clark D, Boyd JH, Finlayson AR, Knight AD, et al. Surgical and Clinical Research (SCAR) Group. Adhesion-related readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24046 patients. Human Reproduction 2004;19(8):1877-85.
27. Mais V, Ajossa S, Marongiu D, Peiretti R, Guerriero S, Melis G. Reduction of adhesion reformation after laparoscopic endometriosis surgery: a randomised trial with an oxidized regenerated cellulose absorbable barrier. Obstetrics and Gynecology 1995;86(4, Pt 1):512-5.
28. Mais V. Peritoneal adhesions after laparoscopic gastrointestinal surgery. World Journal of Gastroenterology 2014;20(17):4917-25.
29. Mettler L, Audebert A, Lehmann-Willenbrock E, Schive-Peterhansi K, Jacobs V. A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility 2004;82(2):398-404.
30. Mettler L, Hucke J, Bojahr B, Tinneberg HR, LeylandN, Avelar R. A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction 2008;23(5):1093-100.
31. Pellicno M, Bramamte S, Cirillo D. Effectiveness of auto-cross linked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective randomised controlled study. Fertility and Sterility 2003;80:441-4.
32. Rennie D. Thyroid storms. JAMA 1997;277:1238-43.
33. Robertson D, Lefebvre G. Adhesion prevention in gynaecological surgery. Journal of Obstetrics and Gynaecology Canada 2010;32:598-608.
34. Practice Committee of the American Society for Reproductive Medicine: Society of Reproductive Surgeons. Pathogenesis, consequences and control of peritoneal adhesions in gynaecological surgery. Fertility and Sterility 2007;88:21-6.
35. Swank DJ, Swank-Bordewijk SC, Hop WC, van Erp WF, Janssen IM, Bonjer HJ, et al. Laparoscopic adhesiolysis in patients with chronic abdominal pain: a blinded randomised controlled multi-centre trial. Lancet 2003;12(361(9365)):1247-51.
36. Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakri J, Kmoshita K. Adhesion prevention effects of fibrin ceilings after laparoscopic myomectomy as determined by second look laparoscopy: a prospective randomised, controlled study. Journal of Reproductive Medicine 2005;50(8):571-7.
37. ten Broek R, Kok-Krant N, Verhoeve HR, van Goor H, Bakkum EA. Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery: results of a randomized control pilot study. Gynaecological Surgery 2012;9:29-35.
38. ten Broek R, Issa Y, Santbrink E, Bouvy N, Kruitwagen R, Jekeel J, et al. Burden of adhesions in abdominal and pelvic surgery: a systematic review and meta-analysis. BMJ 2013;347:f5588.
39. ten Broek R, Stommel M, Stirk C, Laarhoven C, Keus F, Goor H. Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet 2014;383(9911):48-59.
40. Tinelli A, Malvasi A, Guido M, Tsin DA, Hudelist G, Hurs B, et al. Adhesion formation after intracapsular myomectomy with or without adhesion barrier. Fertility and Sterility 2011;95(5):1780-5.
41. Wilson MS, Menzies D, Knight AD, Crowe AM. Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorectal Disease 2002;4(5):355-60.